Mentored Quality Improvement Strategies to Enhance Deprescribing During COVID-19: A Case Series of Three Nursing Homes [0.03%]
COVID-19期间通过师带教进行去处方质量改进策略：三个护理院的病例系列研究
Kristina M Niehoff,April Hanlotxomphou,Mattie Brady et al.
Kristina M Niehoff et al.
Successful deprescribing interventions occurred in all three facilities; however, they did not achieve all QI goals. Conclusion Successful deprescribing can occur using mentored implementation of QI tools.
A physician-pharmacist partnership intervention for deprescribing (P3iD) among older adults attending a falls and syncope clinic: Protocol for a randomised controlled trial [0.03%]
老年人跌倒与晕厥门诊中医生-药剂师合作实施减药干预(P3iD)：随机对照试验方案
Sheron Sir Loon Goh,Pauline Siew Mei Lai,Siti Nurkamilla Ramdzan et al.
Sheron Sir Loon Goh et al.
Therefore, evaluating local deprescribing interventions is essential to produce evidence on their effectiveness in older populations....Findings from this study would inform future deprescribing practices, particularly in LMIC, pertaining to fall prevention as well as aid the development of future deprescribing interventions in other settings.
Randomized Controlled Trial
PloS one. 2025 Jun 3;20(6):e0324565. DOI:10.1371/journal.pone.0324565 2025
Effectiveness of different medication management measures in older patients with chronic diseases and Polypharmacy: A systematic review and network meta-analysis [0.03%]
不同用药管理措施在老年慢性病患者多重用药管理中的有效性的系统评价和网络 meta 分析
Qi Wang,Jiansheng Zhang,Kunpeng Li et al.
Qi Wang et al.
They involved 15794 patients and 7 medication management measures below: medication review (MR), medication record (MRD), deprescribing interventions (DI), medication review with follow-up (MRF), medicine electronic decision support tool (EDS), medication therapy management (MTM), and pharmacotherapy
Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada [0.03%]
加拿大魁北克的一项开药方倡议：描述与思考
Alexandre Campeau Calfat,Maude Gosselin,Caroline Sirois
Alexandre Campeau Calfat
Conclusion: While limitations remain, such as the gradual adoption of billing interventions, Québec's reimbursement model for deprescribing interventions provides an important framework for research, offering a mechanism to study deprescribing in real-world settings.
Pharmacist-led deprescribing interventions for cancer patients in a specialist palliative care setting [0.03%]
专科姑息治疗环境中药师主导的癌症患者药物减量干预措施
Ciarán McAdam,Eimear O&#x;Dwyer,Kieran Dalton
Ciarán McAdam
Purpose: This study aimed to determine the prevalence of potentially inappropriate medications (PIMs) among adult cancer patients in palliative care, the rate at which physicians implemented pharmacists' deprescribing rec...
Jerry H Gurwitz
Jerry H Gurwitz
Medicine Optimisation and Deprescribing Intervention Outcomes for Older People with Dementia or Mild Cognitive Impairment: A Systematic Review [0.03%]
系统综述：药物优化和减少用药干预对痴呆症或轻度认知障碍老年人的效果
Nicola Andrews,Cindy Brooks,Michele Board et al.
Nicola Andrews et al.
This systematic review aimed to summarise the evidence on the outcomes of medicine optimisation and deprescribing interventions for older people with dementia or MCI....Conclusions: Medicine optimisation and deprescribing interventions generally reduced the number and increased the appropriateness of medications, and although less frequently reported, these interventions seemed to be safe and showed an absence of worsening of clinical outcomes.
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review [0.03%]
停药对肌少症参数的影响和证据：系统回顾
Kinda Ibrahim,Natalie J Cox,Stephen E R Lim et al.
Kinda Ibrahim et al.
All studies reporting effects of deprescribing interventions on sarcopenia parameters (primary outcomes) or nutritional intake (secondary outcomes) among older adults were included.
Protocol to evaluate the feasibility of the D-PRESCRIBE intervention adapted to the Belgian community setting (END-IT CS study) [0.03%]
评估D-PRESCRIBE干预措施在比利时社区环境中实施可行性的方案(END-IT CS研究)
Catherine Pétein,Tina Chevallereau,Josephine Aikpitanyi et al.
Catherine Pétein et al.
Introduction: Benzodiazepine receptor agonists (BZRA) deprescribing interventions are needed to tackle high BZRA use in the older population. This study aims to assess the feasibility of the D-PRESCRIBE intervention, adapted from Canada to the Belgian community setting.
Deprescribing in Australian residential aged care facilities: A scoping review [0.03%]
澳大利亚住宅老年护理机构中的停药问题：系统综述
Jenny Xinyu Liang,Louise Thai,Madeleine Healy et al.
Jenny Xinyu Liang et al.
Examining current deprescribing interventions in RACFs would help identify gaps in research knowledge.
耗时 0.09026 秒，为您在
48229835
条记录里面共找到 109 篇文章 [XML]